Abstract:The rapidly evolving nature of antibody drug development has resulted in technologies that generate vast numbers (hundreds to thousands) of lead antibody candidates during early discovery. These candidates must be rapidly pared down to identify the most drug-like candidates for in-depth analysis of their safety and efficacy, which can only be performed on a limited number of antibodies due to time and resource requirements. One key biophysical property of successful antibody therapeutics is high specificity, defined as low levels of nonspecific binding or polyspecificity. Although there has been some progress in developing assays for detecting antibody polyspecificity, most of these assays are limited by poor sensitivity or assay formats that require proprietary antibody surface display methods, and some of these assays use complex and poorly defined polyspecificity reagents. Here we report the PolySpecificity Particle (PSP) assay, a sensitive flow cytometry assay for evaluating antibody nonspecific interactions that overcomes previous limitations and can be used for evaluating diverse types of IgGs, multispecific antibodies and Fc-fusion proteins. Our approach uses micron-sized magnetic beads coated with Protein A to capture antibodies at extremely dilute concentrations (<0.02 mg/mL). Flow cytometry analysis of polyspecificity reagent binding to these conjugates results in sensitive detection of differences in nonspecific interactions for clinical-stage antibodies. Our PSP assay strongly discriminates between antibodies with different levels of polyspecificity using previously reported polyspecificity reagents that are either well-defined proteins or highly complex protein mixtures. Moreover, we also find that a unique reagent, namely ovalbumin, results in the best assay sensitivity and specificity. Importantly, our assay is much more sensitive than standard assays such as ELISAs. We expect that our simple, sensitive, and high-throughput PSP assay will accelerate the development of safe and effective antibody therapeutics.

Previously Unrecognized Nonreproducible Antibody-Probe Interactions

A Computerized Protein–protein Interaction Modeling Study of Ampicillin Antibody Specificity in Relation to Biosensor Development

Previously Unrecognized Non-Reproducible Antibody-Antigen Interactions and Their Implications for Diagnosis of Viral Infections Including COVID-19

Study on interaction between ampicillin antibody and detection interfering proteins by computer aided protein-protein docking for biosensor interesting

Removing Negative Impacts from Inevitable Nonreproducible and Nonspecific Antibody-Probe Interactions in Viral Serology

Single Antibody-Antigen Interactions Monitored Via Transient Ionic Current Recording Using Nanopore Sensors

High-throughput Biomolecular Interaction Analysis Probing by an Array Fluorescent Biosensor Platform

Affinity Separation: Divide and Conquer the Proteome

Co-immunoprecipitations Revisited: an Update on Experimental Concepts and Their Implementation for Sensitive Interactome Investigations of Endogenous Proteins

Unravelling the reason for different binding behaviors exhibited by antibody aggregates towards preparative and analytical protein A columns

Proteochemometric Modeling of the Antigen-Antibody Interaction: New Fingerprints for Antigen, Antibody and Epitope-Paratope Interaction

Novel Allele Detection Tool Benchmark and Application With Antibody Repertoire Sequencing Dataset

Interpretable antibody-antigen interaction prediction by introducing route and priors guidance

A Proximity-Dependent Biosensor System for Visualizing Cell-Cell Interactions Induced by Therapeutic Antibodies

Antibody characterization is critical to enhance reproducibility in biomedical research

Eliminating the Animal Species Constraints in Antibody Selection for Multicolor Immunoassays

Effective and Transient Mapping of Protein-Protein Interactions: Application of Novel Releasable Photoaffinity Linkers.

Highly sensitive detection of antibody nonspecific interactions using flow cytometry

Antibody Watch: Text mining antibody specificity from the literature

When two are better than one: Modeling the mechanisms of antibody mixtures

A new generation of nanobody research tools using improved mass spectrometry-based discovery methods